Frontiers in Pharmacology (Oct 2022)

Editorial: Advances on targeted nanomedicines for atherosclerosis

  • Qinggong Han,
  • Hongliang He,
  • Yu Zhang

DOI
https://doi.org/10.3389/fphar.2022.1053938
Journal volume & issue
Vol. 13

Abstract

Read online

GRAPHICAL ABSTRACTThe importance of nanomedicines for atherosclerosis.

Keywords